期刊文献+

微嵌合体在母亲子女之间活体肾移植中的作用 被引量:4

Analysis of microchimerism in living renal transplantation between mothers and children relationship
原文传递
导出
摘要 目的观察不同供受体关系亲属活体肾移植的临床疗效及其与微嵌合体之间的关系。方法回顾性分析复旦大学附属中山医院2004-2008年130例亲属肾移植临床资料。受者随访1—5年,利用微卫星及性染色体决定基因聚合酶链反应(PCR)技术检测外周血DNA微嵌合体,并根据随访结果,分析微嵌合体的作用。结果受者1-年人/肾存活率分别为93.8%和92.3%,各供受者组关系比较发现1-年人/肾存活率差异均无统计学意义(均P〉0.05)。130例受者中46例(35.4%)行移植肾穿刺活检,病理结果证实发生急性排斥反应26例,急性排斥反应发生率为20.0%(26/130)。26例中14例(53.8%)为母亲子女之间。肾移植,12例(46.2%)为其他供受者关系肾移植。母亲子女肾移植中急排斥反应发生率为30.4%(14/46),高于其他供受者关系肾移植急性排斥反应发生率(14.3%,12/84,P=0.028)。130例受者中43例术后不同时间进行了外周血微嵌合体检测,在其中16例母亲供肾的受者中,4例检测到微嵌合体,阳性率25.0%;27例其他供者的受者中,4例检测到微嵌合体,阳性率为(4.8%;母亲供肾微嵌合体阳性率比其他关系高约1倍。微嵌合体阳性组急性排斥反应发生率较微嵌合体阴性组高约1倍。结论母亲子女之间肾移植急性排斥发生率较高;母亲供肾的微嵌合率较高;微嵌合率高的组别急性排斥反应较高;母亲子女之间特殊的免疫学关系可能影响肾移植效果。 Objective To compare the microchimeric and rejection rates in living donor kidney transplant recipients in mother and child relations arid other relations, Methods This retrospective single- center study enrolled 130 recipients to receive allografts from living related donors from 2004 to 2008 at our hospital. They were followed up for 1 - 5 years. The demographic data of the study population were analyzed by basic statistical methods. A total of 43 recipient blood samples were collected for the detection of microchimerism by the assays of short tandem repeat (STR) and sex-determining region-y gene (SRY) polymerase chain reaction (PCR). Results The 1-year patient/graft survival rates were 93.8% and 92. 3% respectively. And there was no significant differences between mother and child group and other relative group. Forty-six biopsy samples were collected from 46 recipients. Twenty-six (20. 0% ) cases had the occurrences of acute rejection episodes in different Banff degrees as proven by biopsy. 53.8% (14/26)cases were mother and child renal transplantation, higher than other relative (46. 2%, 12/26 ) . The mother donor kidney transplant recipients had about a twice higher rejection rate (30. 4% vs 14. 3%, P = 0. 028 ) and a twice higher microchimeric rate(25.0% vs 14. 8% ) than other relative. Conclusion Compared with other relations, the mother donor kidney recipients tend to have higher rates of microchimerism and acute rejection. And the special immune effect in mothers and children renal transplantation may influence its outcomes.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第8期508-511,共4页 National Medical Journal of China
基金 基金项目:“十一五”国家科技支撑计划(2008BA160804) 国家自然科学基金面上项目(81070595) 上海市科学技术委员会医学重点项目(09411952000、09DZ2260300、10DZ2212000)
关键词 肾移植 活体供者 移植物排斥 移植嵌合体 母亲供肾 Kidney transplantation Living donors Graft rejection Transplantation
  • 相关文献

参考文献12

  • 1Sayegh MH, Carpenter CB. Transplantation 50 years later: progress, challenges, and promises. N Engl J Med, 2004,351 : 2761-2766.
  • 2OPTN/SRTR Data. OPTN/SRTR 2008 annual report [R/OL]. 2008 [2008-05-01]. http ://optn. transplant, hrsa. gov/.
  • 3王宣传,戎瑞明,朱同玉,许明,刘宇军,孙立安,王国民.父母作为供体的肾移植临床疗效比较[J].复旦学报(医学版),2009,36(3):257-260. 被引量:5
  • 4王宣传,许明,朱同玉,戎瑞明,唐群业,孙立安,王国民.夫妻间活体供肾肾移植的疗效分析[J].中国临床医学,2010,17(3):376-377. 被引量:3
  • 5Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation, 1993,55 : 1272-1277.
  • 6Pujal JM, Gallardo D. PCR-based methodology for molecular microchimerism detection and quantification. Exp Biol Med,2008, 233:1161-1170.
  • 7Fleiner F, Fritsche L, Glander P, et al. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection .9 Transplantation ,2006,81:655-659.
  • 8Miles CD, Schaubel DE, Liu D, et al. The role of donor-recipient relationship in long-term outcomes of living donor renal transplantation. Transplantation, 2008 ,85 : 1483-1488.
  • 9Ferlicot S, Vernochet A, Romana S, et al. Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells. Histopathology, 2010,56 : 188-197.
  • 10Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang, 1986,51:117-121.

二级参考文献18

  • 1Sayegh MH,Carpenter CB.Transplantation 50 years later:progress,challenges,and promises[J].N Engl J Med,2004,351:2 761-2 766.
  • 2Starzl TE,Murase N,Abu-Elmagd K,et al.Tolerogenic immunosuppression for organ transplantation[J].Lancet,2003,361(9 368):1 502-1 510.
  • 3Scandling JD,Busque S,Dejbakhsh-Jones S,et al.Tolerance and chimerism after renal and hematopoietic-cell transplantation[J].N Engl J Med,2008,358:362-368.
  • 4O'Donoghue K,Chan J,de la Fuente J,et al.Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy[J].Lancet,2004,364:179-182.
  • 5Mahanty HD,Cherikh WS,Chang GJ,et al.Influence of pretransplant pregnancy on survival of renal allografts from living donors[J].Transplantation,2001,72:228-232.
  • 6Guba M,Jauch KW,Kruger B,et al.Reduced exposure to calcineurin inhibitors in renal transplantation[J].N Engl J Med,2007,357:2 562-2 575.
  • 7Fleiner,Franca,Fritsche,et al.Reporting of rejection after renal transplantation in large immunosuppressive trials:biopsy-proven,clinical,presumed,or treated rejection?[J].Transplantation,2006,81(5):655-659.
  • 8Miles CD,Schaubel DE,Liu D,et al.The role of donor-recipient relationship in long-term outcomes of living donor renal transplantation[J].Transplantation,2008,85(10):1 483-1 488.
  • 9Monaco AP.Prospects and strategies for clinical tolerance[J].Transplant Proc,2004,36:227-231.
  • 10Gibney EM,Parikh CR,Garg AX.Age,gender,race,and associations with kidney failure following living kidney donation[J].Transplant Proc,2008,40(5):1 337-1 340.

共引文献6

同被引文献23

  • 1金昊,昌盛.亲属活体肾移植的发展和现状[J].中华器官移植杂志,2006,27(5):318-320. 被引量:35
  • 2Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renaltransplantation without maintenance immunosuppressioa N Engl JMed, 2008,358(4):353-361.
  • 3Scandling JD, Busque S,Dej bakhsh-J ones S, et al. Toleranceand chimerism after renal and hematopoietic-celltransplantation. N Engl J Med. 2008,358(4) : 362-368.
  • 4Wu D,Qi G,Wang X,et al. Hematopoietic stem celltransplantation induces immunologic tolerance in renaltransplant patients via modulation of inflammatory and repairprocesses. J Transl Med, 2012, 10: 182.
  • 5Sayegh MH, Carpenter CB. Transplantation 50 years later—progress,challenges,and promises. N Engl J Med,2004,351.26):2761-2766.
  • 6Kawai T, Sogawa H, Boskovic S,et al. CDl54 blockade forinduction of mixed chimerism and prolonged renal allograftsurvival in nonhuman primates. Am J Transplant, 2004, 4(9):1391-1398.
  • 7Locascio SA, Morokata T,Chittenden M. et al. Mixedchimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidneyand bone marrow transplantation to induce tolerance.Transplantation,2010, 90(12) : 1607-1615.
  • 8Leventhal J, Abecassis M,Miller J, et al. Toleranceinduction in HLA disparate living donor kidney transplantationby donor stem cell infusion; durablechimerism predictsoutcome. Transplantation,2013,95(1) : 169-176.
  • 9Kuruvila CK,Mccalmon RT, Schreiber DP, et al. Totallymphoid irradiation for pretransplant immunosuppression :nine year follow-up. Kidney Int Suppl, 1997,61 :S89-92.
  • 10Taylor RB. Fortney JA, Pollack RB,et al. Radiation therapyfor B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol,2010,28(5):385-387.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部